Table 2.
Association between RGS17 expression and disease parameters in 87 cases of breast cancers.
| Total | RGS17 | P-value | |||||
|---|---|---|---|---|---|---|---|
| - | + | ++ | +++ | ||||
| n=3 | n=10 | n=18 | n=56 | ||||
| TNM stage | |||||||
| I and Ⅱ | 80 | 2 | 9 | 17 | 52 | 0.497 | |
| Ⅲ and Ⅳ | 7 | 1 | 1 | 1 | 4 | ||
| Tumor size | |||||||
| ≤2cm | 66 | 3 | 8 | 13 | 42 | 0.578 | |
| 2cm<T≤5cm | 19 | 0 | 2 | 5 | 12 | ||
| >5cm | 2 | 0 | 0 | 0 | 2 | ||
| Lymph node metastasis | |||||||
| Negative | 53 | 2 | 6 | 10 | 35 | 0.755 | |
| Positive | 34 | 1 | 4 | 8 | 21 | ||
| Age | |||||||
| <50 | 27 | 2 | 2 | 5 | 18 | 0.859 | |
| ≥50 | 60 | 1 | 8 | 13 | 38 | ||
TNM stage is a classification of malignant tumors used by the International Federation of Gynecology and Obstetrics (FIGO). T describes the size of primary tumor, N describes nearby lymph nodes that are involved, and M describes distant metastasis.